Hematology is in our blood
Boule Diagnostics AB is a company with a strong heritage when it comes to hematology diagnostics. We developed the very first European blood cell counter, and today our instruments, reagents, calibrators and controls are used by healthcare providers around the world. Boule’s products are currently on sale in more than 100 countries.
Our blood tests help provide one of the first and most important indicators of a disease state and Boule systems play an increasingly important role in helping build the infrastructure of healthcare for small and medium size patient care environments in both human and veterinary markets.
Boule is listed on NASDAQ Stockholm since June 2011.
Interview with Boules CEO Fredrik Dalborg answering questions about Q4 2017.
Press & news
Financial Calendar
Event
Welcome to visit us at
AACC Annual Scientific Meeting & Clinical Lab Expo
29 July – 2 August, Chicago, Il
Company in figures 2016
Net sales, SEK million
(increased by 21%)
Operating margin
(increased by 118%)
Gross margin
(increased by 4%)
Equity/assets ratio
(increased by 5%)
